Objectives: Persistent infection with human papillomavirus causes cervical high-grade squamous intraepithelial lesions (HSILs). The role of antimicrobial peptides (AMPs) in premalignant and malignant transformation is not fully understood. In this study, we examined the expression of human β-defensin 1 (HBD-1), HBD-2, HBD-3, LL37, psoriasin, and interleukin 8 (IL-8) in women with HSIL before and 6 months after surgery.
H uman papillomavirus (HPV) infection is globally the most common sexually transmitted infection. 1 Most women will effectively eliminate the virus. However, approximately 15% will not become HPV negative leading to a persistent infection, which may progress to cervical low-or high-grade squamous intraepithelial lesions (LSILs, HSILs) with the potential to develop to invasive squamous cell carcinoma (SCC). 2 There is a known association between persistent infection, chronic inflammation, and cancer. The constant cell renewal in chronic inflammation leads to acceleration of cell division and an increased risk of mutation and neoplastic transformation. 3 The innate immune system is important for the defense of HPV infections and plays an important role in the activation of the adaptive immune response. 4, 5 Antimicrobial peptides (AMPs) are part of the innate immune system and exhibit diverse mechanisms of actions against bacteria, viruses, fungi, and protozoa. 4, 6, 7 Antimicrobial peptides are mostly cationic, amphipathic peptides with 12 to 50 amino acids, present in epithelial and phagocytic cells such as neutrophils and macrophages. 8 The following are the 3 large groups of AMPs in humans: defensins, cathelicidins, and S100 proteins. α-Defensins are predominately expressed in neutrophils or intestinal epithelial cells, important for mucosal antimicrobial activity. The α-defensin 5 (HD5) is a potent antagonist of viral infections, present in the female genital tract. 9 The β-defensins also play a key role in the innate immunity to infections. Human β-defensin 1 (HBD-1) is constitutively expressed, whereas HBD-2 and HBD-3 are induced by infectious and inflammatory stimuli. 10, 11 The cathelicidin, LL37, is present in humans and has been demonstrated to have antimicrobial and immunomodulatory activity. 4, 12 S100A7 (psoriasin) belongs to the S100 protein family, which consists of several Ca 2+ -binding proteins. It is involved in several cellular processes such as cell proliferation, apoptosis, and differentiation. 13 Psoriasin is a monomeric peptide composed of 101 amino acids with a molecular weight of 11.46 kDa. 14 The peptide is constitutively expressed by epithelial cells of skin and mucous membranes and has been detected in secretions of the urogenital tract. 13, 15, 16 Psoriasin is up-regulated during a variety of inflammatory and hyperproliferative skin diseases. 15 The antibacterial activity is dependent on its zinc-binding motif. 17, 18 It has been shown that psoriasin has a potent Escherichia coli-cidal activity, but less antimicrobial effect against other bacteria and fungus. 18, 19 In several tumors, psoriasin is overexpressed and is considered to have the potential to promote tumor progression through different signaling pathways. 13, [20] [21] [22] Antimicrobial peptides in relation to HPV persistence and the risk to develop precancerous lesions are only partly surveyed. For cutaneous and oral SCCs, it has been suggested that HBD-1 acts as a tumor suppressor. 21, 23 The role of psoriasin in HPV-induced lesions of the cervix has, however, not previously been described.
In this study, we examined the expression of the AMPs HBD-1, HBD-2, HBD-3, LL37, and psoriasin as well as the proinflammatory cytokine interleukin 8 (IL-8) in patients with cervical HSIL and healthy controls. Cervical biopsies and secretion samples from the cervical canal were analyzed before and 6 months after surgical excision.
MATERIALS AND METHODS

Participants and Sampling
Women attending the national cervical screening program with test results indicating HSIL were invited to participate in the study. The study was conducted at the gynecology outpatient clinic at Danderyd Hospital, Stockholm, Sweden, and was approved by the regional ethics committee in Stockholm. Written informed consent was received from all participants before inclusion in the study.
The inclusion criterion was histopathological diagnosis of HSIL verified in surgical specimens after conization by 2 independent pathologists and concomitant negative vaginal culture. Nineteen women with HSIL, with a mean age of 30 years (range = 23-40 years), were included in the study. Fourteen women with no history of LSIL or HSIL, with a mean age of 31 years (range = 23-39 years), were recruited as healthy controls. Exclusion criteria for both patients and controls were severe illness, pregnancy, and concomitant genital infections such as chlamydia trachomatis, bacterial vaginosis, and candida infection. Additional exclusion criteria for all participants were vaginal treatments of any kind, vaginal intercourse the last 24 hours, vaginal douching and ongoing menstruation, as well as current antibiotic treatment or other medications such as corticosteroids that may influence the immune system.
The participants completed a standardized questionnaire on medical and reproductive history including lifestyle factors and contraceptive use. All participants underwent a gynecological examination with inspection of the vulva and the vagina. Microscopy of wet mount was carried out for Candida and trichomonas infections and specimens for bacterial, fungal culture, and chlamydia polymerase chain reaction (PCR) were collected. Amsel's criteria were used for exclusion of bacterial vaginosis (vaginal pH > 4.5, positive whiff test, homogenous vaginal discharge, and presence of clue cells). 24 Liquid-based cytology, including detection of high-risk HPV (HPV), was obtained and colposcopy performed according to normal routine to identify suspect cervical dysplasia.
Sampling of secretion from the cervical canal was performed by rotating a cytobrush 2 turns. 25 The cytobrush was stirred for 1 minute in a test tube containing 3 ml of sterile water before centrifugation at 300g for 10 minutes, according to a modified method described by Valore et al. 26 The cell pellet and the supernatant were stored separately at −80°C.
Cervical biopsies of 3 mm were obtained with forceps from the cervical transformation zone after colposcopy. One biopsy was sent for histopathological analysis. A second biopsy was placed in RNA later and subjected to RNA isolation and gene expression analysis. The third biopsy was fixed in 4% paraformaldehyde at 4°C for 24 hours, then placed in 70% ethanol, and thereafter paraffin embedded and processed for immunohistochemical analyses.
All patients with HSIL were treated with conization (laser or loop excision) and came back for follow-up 6 months after surgery. At the second visit, all examinations and samplings were repeated according to the same protocol at the first visit. The controls came for 1 single visit.
Total RNA Extraction and Real-Time PCR Analysis
Total RNA was extracted using the RNase Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. The concentration and purity of RNAwere determined with Nanodrop, and up to 1 μg of RNA was transcribed to cDNA using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific Baltics, Vilnius, Lithuania). Gene expression was analyzed with TaqMan gene expression assays (Thermo Fisher Scientific Baltics) for IL-8 (CXCL-8, Hs00174103_m1) and the AMPs HBD-1 (DEFB1, Hs00608345_m1), HBD-2 (DEFB4A, Hs00175474_m1), HBD-3 (DEFB103A, Hs00218678_m1), psoriasin (S100A7, Hs00161488_m1), and human cathelicidin (LL-37/hCAP-18, CAMP, Hs00189038_m1) using a Rotor-Gene PCR cycler (Corbett Life Science, Hilden, Germany). 18S (18s, Hs03003631_g1) and human GAPD (GAPDH, 4326317E) were used as housekeeping genes with similar results. Relative expressions of target genes were presented as 2-ΔCT and fold change as 2-ΔΔCT compared with controls. Because of the lack of sufficient amount of material, the mRNA analyzes were carried out consecutively in 14 of the 19 patients and in 12 of the 14 healthy controls.
Enzyme-Linked Immunosorbent Assay
Supernatant from the cytobrush samples were analyzed using ELISA for psoriasin (CirculexTM; MBL International, Woburn, MA) and IL-8 (Human CXCL8/IL-8 DuoSet; R&D Systems, Minneapolis, MN) according to the manufacturer's recommendations. The levels of psoriasin and IL-8 in each sample are presented as the ratio of these proteins and the total protein content in cytobrush samples determined by using BCA assay (PierceTM, Thermo Fisher Scientific Baltics).
Immunohistochemistry
Biopsies collected for immunohistochemical analysis were paraffin embedded and cut at 4 μm. Sections were deparaffinized in xylene, rehydrated in an ethanol gradient, and washed in water and PBS. Heat-mediated antigen retrieval was performed in citrate buffer (10 mM, pH 6) and sections were blocked for 30 minutes with Image-iT FX Signal Enhancer (Life Technologies) and for 60 minutes with 10% serum from the species that the secondary antibody was raised in. Overnight incubation with primary antibodies was carried out at 4°C. Primary antibody used was rabbit antipsoriasin (1:800; Abcam, Cambridge, United Kingdom). Sections were then incubated with Alexa Fluor-conjugated secondary antibody (Life Technologies) for 30 to 60 minutes at room temperature and mounted in ProlongGold Antifade mounting medium with DAPI (Life Technologies). Negative control sections were prepared by omitting the primary antibody during incubation. Images were acquired on a Leica SP5 confocal microscope (Wetzlar, Germany) using a 40Â objective.
Statistics
Data were analyzed using GraphPad Prism, Version 6, and IBM SPSS Statistics for Windows, Version 22. For comparison of clinical characteristics between patients and controls, Student t test and Fisher exact test were used as appropriate. The Kruskal Wallis test with Dunn multiple comparison tests was used for the initial analyses of mRNA expressions of all tested AMPs in patients before and after treatment. Thereafter, the MannWhitney U test was used for analyzing the mRNA expression and protein levels for psoriasin and IL-8 between patients and controls and Wilcoxon signed-rank test for comparing the same analyses in patients before and after treatment. Pearson correlation coefficient was used for correlation analyses between psoriasin and IL-8. All tests were performed two-sided and differences with p values < 0.05 were considered statistically significant.
Role of the Funding Source
The reported funding has been used to cover the expenses of the methods used in the study.
RESULTS
No differences between patients and controls were observed regarding age, body mass index, parity, smoking habits, or contraceptive use. The history of genital infections was similar. Three patients reported previous cervical dysplasia of mild degree (LSIL) (see Table 1 ).
After conization, the final inclusion of the 19 patients was decided based on HSIL diagnosis in the surgical specimens. At the second visit, 6 months after surgery, 3 patients had mild atypia in liquid-based cytology. In the biopsies, no dysplasia was found in 14 patients, mild dysplasia (LSIL) was diagnosed in 1 patient, who had normal cytology, and 4 patients declined the diagnostic biopsy procedure. All patients were positive for high-risk HPV before treatment. At the follow-up after conization, all but 2 were HPV negative. The HPV-positive patients also had mild atypia in cytology and needed further clinical follow-ups. All controls were HPV negative and had benign biopsies and cytology at the recruitment visit.
Before surgical treatment, the psoriasin mRNA expression was lower (p = .05) in patients than in controls (see Figure 1A) . Six months after conization, the mRNA expression was significantly increased (p = .04) and reached the same level as in the healthy controls (see Figure 1A) . The protein levels of psoriasin increased significantly after surgical treatment (p = .03), with similar levels as controls (see Figure 1B) . Psoriasin was localized in the cytoplasm of the upper epithelial cells. After conization, the immunostaining was distinct in contrast to the weak staining of the presurgical section (see Figures 2A-C) .
No differences in mRNA levels of HBD-1, HBD-2, HBD-3, or LL37 were observed in the patients before and after treatment and in controls. Protein analyses were therefore not performed.
The relative expression of IL-8 mRNA was significantly higher before treatment than 6 months after surgery (p = .05). No differences were observed compared with controls (see Figure 3A) . On the protein level, no differences were observed between patients before or after surgery or compared with controls (see Figure 3B) .
Interestingly, after treatment, we observed a positive correlation between psoriasin and IL-8 on both mRNA (R 2 = 0.57, p = .03) and protein levels (R 2 = 0.59, p = .01).
DISCUSSION
In this study, we analyzed the expression of AMPs, with special focus on psoriasin in cervical HSIL. Our results showed that the expression of psoriasin was lower in patients with HSIL on both the mRNA and protein levels before the lesions were excised compared with after treatment. The persistence of HPV infections is likely due to immune evasion of which several mechanisms have been described. 1, 27, 28 Of importance is that HPV do not replicate in antigen-presenting cells and by not lysing epithelial cells they avoid recognition by the immune system. Despite the lack of typical immune response with tissue damage, evidence show that persistent HPV infection induces a chronic inflammation, which plays a role in the development of HPV-associated carcinogenesis. 3 In the present study, the expression of psoriasin in patients with HSIL was significantly lower on both the mRNA and protein levels before treatment. After the surgical excision, the expression increased to the same levels as in the healthy controls. Psoriasin has previously been detected in vaginal fluid but not in tissue samples from the cervical mucosa. 16 Under normal conditions, psoriasin mRNA is higher in oral mucosa, compared with extraoral skin. On the protein level, however, the relationship is the opposite with the highest amount of protein located in the keratinized layers. 29 These findings indicate that the role of AMPs may differ depending on their localization. It is likely that psoriasin conducts its activity on the mucosal surface as well as intracellularly, interfering with chronic infections. This speculation is in line with our result of higher psoriasin levels in postsurgical samples of cervical mucosa. Psoriasin is involved in keratinocyte differentiation and enhance the expression of several differentiation markers. It has also been shown that psoriasin promotes endothelial cell proliferation by enhancing vascular endothelial growth factor, an important protein in the angiogenesis in both cancer and chronic inflammation. 30, 31 Our results differ from the findings in previous studies on epithelial skin tumors, where it was shown that precancerous lesions displayed higher expression of psoriasin compared with invasive disease and control samples. 20, 21 Scola et al. 21 also suggested that the increased psoriasin expression correlates to the progression from premalignant skin lesions into invasive cancer. In breast cancer, the expression of psoriasin is considered to correlate with tumor progression with poorer prognosis, and it has even been suggested as a candidate diagnostic marker. 32 In the current study, the premalignant cervical lesions were all induced by high-risk HPV viruses. Mucosal HPV infection does not normally cause a major inflammatory tissue reaction or a considerable proliferative state. One might speculate whether there is a difference in the inflammatory response in HPV versus non-HPV-induced premalignant lesions. In inflammatory skin diseases, such as psoriasis, there is a hyperproliferation of the epithelium, 15 which is not seen in HSIL of the cervical mucosa. Erhart et al. 33 have shown that in benign proliferative vulvar condylomas, the expression of psoriasin is significantly up-regulated compared with normal controls, which is in line with the theory of psoriasin being a part of the proliferative process. Our results indicate that psoriasin might be down-regulated in the HPVinduced mucosal lesions. This is in agreement with the results of a study demonstrating reduced psoriasin levels in samples from patients colonized with β-hemolytic streptococci (group A, C, or G) and/or Haemophilus influenza undergoing tonsillectomy in a nonacute phase without clinical signs of infection. 34 Because psoriasin has chemotactic properties, 13 it is tempting to speculate that the reduction of psoriasin is part of the HPV-premalignant process by reducing the immunological response in the tissue. However, it could be discussed if the low psoriasin levels are a prerequisite for persistent HPV infections or vice versa that the chronic HPV infection contributes to the low psoriasin levels observed.
To follow the inflammatory response before and after treatment, IL-8 was chosen as a marker of inflammation. The mRNA expression of IL-8 was significantly higher in patients with HSIL lesions before treatment as compared with postsurgical levels. However, the results could not be confirmed on the protein level in the cytobrush samples. Our findings are in line with previous results of elevated IL-8 expression in SCC 20 and in cervical intraepithelial neoplasia. 35 Altered levels of cytokines are suggested to play a role in the transformation from persistent infection to malignant lesions. 3 It was shown by Scott et al. 36 that in persistent highrisk HPV infection the proinflammatory and regulatory cytokines are elevated leading to corresponding long-term activation of the immune mediators for viral clearance. When a cervical high-risk HPV infection is cleared, the elevated cytokine expression is reversed to normal levels, also shown in our study. This finding is further supported by the positive correlation between psoriasin and IL-8 after treatment.
Major strengths of this study are the strict sampling with well-defined inclusion and exclusion criteria and that the potential impact of co-infections is excluded. Furthermore, the analyses of AMP and IL-8 were performed on gene and protein levels before and after treatment in the same patients, and finally, the histopathological diagnosis was verified by 2 independent pathologists. However, the study lacks samples from patients with cervical cancer, which further imply the need for more research to clarify the role of AMPs in HPV-induced premalignant and malignant processes in the female lower genital tract. In this context, including analyses of HD5 would have improved the study. α-Defensin 5 has been shown to have potent antiviral activity, especially for sexually transmission of HPV infections. 9 However, an interesting finding is that HD5 was almost absent in the transformation zone in cervical HSIL, 37 suggesting that HD5 deficiency might play an important role in the pathogenesis of HPV.
Another limitations in our study are the small sample size and the use of multiple comparisons of psoriasin and IL-8 with p < .05 as a significant level. However, the combination of significance changes in psoriasin mRNA and protein product strengthens the statistical inference. We would also like to acknowledge the lack of menstrual data. Some of the other analyzed AMPs have been shown to vary during the menstrual cycle. However, the cyclic regulation is repealed in oral contraceptive and levonorgestrel intrauterine device users, and our study groups did not differ in these considerations. 4 
CONCLUSIONS
In premalignant HPV-induced cervical HSIL, the expression of the AMP psoriasin is lower on gene expression and protein levels before treatment. Six months after surgical treatment, when the HPV infection was cleared, the levels were the same as in healthy controls, and there was a corresponding reduction of mRNA expression of IL-8. Psoriasin might in the future be part of a panel of clinical biomarkers aimed to detect precancerous and possible malignant conditions. Furthermore, synthetic nontoxic psoriasin might be an option to prevent infections with the potential to cause precancerous lesions.
